Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Assay test kits
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Assay test kits

[0544-MBS2548424-100] CHAT assay Test :: Choline Acetyltransferase (CHAT) Assay Test, 100 tests
CHAT assay Test :: Choline Acetyltransferase (CHAT) Assay Test, 100 tests
591.00 € 591.0 EUR
[0544-MBS7255958-96T] CER elisa Test :: Mouse Ceramide ELISA Test - 96 Tests
CER elisa Test :: Mouse Ceramide ELISA Test - 96 Tests
952.00 € 952.0 EUR
[0544-MBS743911-96T] CER elisa Test :: Bovine Ceruloplasmin ELISA Test - 96 Tests
CER elisa Test :: Bovine Ceruloplasmin ELISA Test - 96 Tests
1,030.00 € 1030.0 EUR
[0852-INV-1131] CEA Test Strip Medical IVD rapid diagnostic test Tests 3.0mm 100 Tests/Test
CEA Test Strip Medical IVD rapid diagnostic test Tests 3.0mm 100 Tests/Test
135.20 € 135.2 EUR
[0149-36PP5.52-100 Tests] CD36 PerCP-Cy5.5 (kloon CLB-IVC7), 100 ug.
CD36 PerCP-Cy5.5 (kloon CLB-IVC7), 100 ug.
758.00 € 758.0 EUR
[0247-OASA03656-100 Tests] CD163 Antibody - PE Conjug.ated
CD163 Antibody - PE Conjug.ated
1,086.00 € 1086.0 EUR
[0022-KAPEPKT849] CALPROTECTIN ELISA   96 TESTS
CALPROTECTIN ELISA 96 TESTS
467.00 € 467.0 EUR
[0544-MBS2702620-96T] C2 elisa Test :: Human Complement Component 2 (C2) ELISA Test, 96 tests
C2 elisa Test :: Human Complement Component 2 (C2) ELISA Test, 96 tests
595.00 € 595.0 EUR
[0987-VVD20] C. Brucella Rapid Antibody Test Test - S/P/WB - 10 Tests
C. Brucella Rapid Antibody Test Test - S/P/WB - 10 Tests
122.50 € 122.5 EUR
[0597-Oneq-V156-50D] Burkholderia mallei detection Tests - 50 reactions
Burkholderia mallei detection Tests - 50 reactions
850.00 € 850.0 EUR
[0597-PCR-VH075-96D] Brucella canis detection Tests End-Point Q96rxs
Brucella canis detection Tests End-Point Q96rxs
755.00 € 755.0 EUR
[0597-PCR-VH075-48D] Brucella canis detection Tests End-Point Q48rxs
Brucella canis detection Tests End-Point Q48rxs
635.00 € 635.0 EUR
[0556-N26-VCM007] Brucella Virclia® IgM Monotest 24 Tests
Brucella Virclia® IgM Monotest 24 Tests
335.00 € 335.0 EUR
[0597-Oneq-V199-150D] Bovine papillomavirus 13 types detection Tests -150 Reactions
Bovine papillomavirus 13 types detection Tests -150 Reactions
1,100.00 € 1100.0 EUR
[0964-FE005] Bovine Mycobacterium tuberculosis Anticorps ELISA Test - 96 tests
Bovine Mycobacterium tuberculosis Anticorps ELISA Test - 96 tests
351.00 € 351.0 EUR
[0772-E0016Bi -96T] Bird Thyroid Stimulating Hormone,TSH ELISA Test, 96 tests
Bird Thyroid Stimulating Hormone,TSH ELISA Test, 96 tests
550.00 € 550.0 EUR
[0767-GRS-20059] Bird Flu H5 Antigen Rapid Test Card - 25Tests/Test
Bird Flu H5 Antigen Rapid Test Card - 25Tests/Test
250.00 € 250.0 EUR
[0767-GRS-20058] Bird Flu H5 Antibody Rapid Test Card - 25Tests/Test
Bird Flu H5 Antibody Rapid Test Card - 25Tests/Test
250.00 € 250.0 EUR
[0617-EKF60026-96T] Biotin ELISA Test - 96 Tests
Biotin ELISA Test - 96 Tests
915.45 € 915.45 EUR
[0173-AF06FK10T] Bioline SYPHILIS 3.0, 30 tests/Test
Bioline SYPHILIS 3.0, 30 tests/Test
136.00 € 136.0 EUR
  • 2
  • 3
  • 4
  • 5
  • 6

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)